Adaptive Biotechnologies Corp
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Seattle, WA
ADPT chart
What traders are saying about $ADPT
Latest postsAdaptive Biotechnologies Corp news
- Is Adaptive Biotechnologies (ADPT) Still Below Fair Value On Mixed Q3 Results?
Simply Wall St ·
- Adaptive Biotechnologies (ADPT) Reported Mixed Q3 Results, Is The Stock Fully Valued?
Yahoo Finance ·
- Adaptive Biotechnologies (NASDAQ:ADPT) Stock: Insider Julie Rubinstein Sells 11,881 Shares
MarketBeat ·
- Adaptive Biotechnologies president and COO Julie Rubinstein sells $954k stock
Investing.com ·
- Form 4 Adaptive Biotechnologies Corp: Julie Rubinstein (President and COO) For: 4 November By Investing.com
Investing.com India ·
- Adaptive Biotechnologies Corporation $ADPT Stock Sold by Sumitomo Mitsui Trust Group Inc.
MarketBeat ·
- Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Stock Has Average Target Price of $30.06
MarketBeat ·
- Adaptive Bio Raises Full-Year MRD Revenue Outlook as Clinical Volume Continues to Grow
GenomeWeb ·
- Adaptive (ADPT) Q3 2026 Earnings Call Transcript
fool.com ·
- TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $34
Moomoo ·
- Quarterly Sales Slip Might Change The Case For Investing In Adaptive Biotechnologies (ADPT)
Simply Wall St ·
- Adaptive Biotechnologies Corp (ADPT) Q3 2026 Earnings Call Highlights: First Profitable Quarter ...
Yahoo Finance ·
Adaptive Biotechnologies Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $277.0M | $179.0M | $170.3M | $185.3M |
| Net income | -$59.5M | -$159.5M | -$225.3M | -$200.2M |
| Diluted EPS | $-0.39 | $-1.08 | $-1.56 | $-1.40 |
| Total assets (year end) | $512.7M | $539.4M | $661.1M | $856.6M |
| Cash and equivalents (year end) | $70.5M | $47.9M | $65.1M | $90.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Adaptive Biotechnologies Corp
- Ticker
- ADPT (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Seattle, WA
- Incorporated in
- WA
- Fiscal year end
- December 31
- SEC CIK
- 1478320
- Former names
- Adaptive TCR Corp
Frequently asked questions
What exchange is Adaptive Biotechnologies Corp listed on?
Adaptive Biotechnologies Corp trades on the Nasdaq under the ticker symbol ADPT.
What industry is Adaptive Biotechnologies Corp in?
Adaptive Biotechnologies Corp is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Adaptive Biotechnologies Corp headquartered?
Adaptive Biotechnologies Corp's business address on file with the SEC is in Seattle, WA.
When does Adaptive Biotechnologies Corp's fiscal year end?
Adaptive Biotechnologies Corp's fiscal year ends on December 31.
How much revenue did Adaptive Biotechnologies Corp report?
Adaptive Biotechnologies Corp reported $277.0M in revenue for calendar year 2025, according to its SEC filings.